Wang, Zelun https://orcid.org/0000-0003-3768-6934
Zhao, Christopher
Xu, Shelly
Zhao, Minglei
McCracken, Sean
Apte, Rajendra S. https://orcid.org/0000-0003-2281-2336
Williams, Philip R. https://orcid.org/0000-0003-4813-8925
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Eye Institute (R01 EY032908)
U.S. Department of Health & Human Services | NIH | National Eye Institute (R01 EY035684)
U.S. Department of Health & Human Services | NIH | National Eye Institute (R01 EY036111)
U.S. Department of Health & Human Services | NIH | National Eye Institute (R01 EY012543)
U.S. Department of Health & Human Services | NIH | National Eye Institute (P30 EY002687)
U.S. Department of Health & Human Services | NIH | National Eye Institute (T32 EY013360)
U.S. Department of Health & Human Services | NIH | National Eye Institute (T32 EY013360)
Research to Prevent Blindness (Young Investigator Award)
Research to Prevent Blindness (Unrestricted grant to Department of Ophthalmology)
Novartis | Alcon | Alcon Research Institute (Young Investigator Award)
BrightFocus Foundation (National Glaucoma Award)
Article History
Received: 26 February 2025
Accepted: 10 March 2026
First Online: 27 March 2026
Competing interests
: Rajendra S. Apte is a co-founder of Metro Biotech LLC. The other authors declare no competing interests.